Today: 19 May 2026
SSE share price nudges higher as BoE rate call and trading update loom
2 February 2026
1 min read

SSE share price nudges higher as BoE rate call and trading update loom

London, Feb 2, 2026, 09:34 (GMT) — Regular session

  • SSE shares edged up 0.04% to 2,422.93 pence in early trading, hovering close to a 52-week peak
  • Utility stocks held firm amid investor caution over interest-rate cues and a risk-averse market mood
  • Attention shifts to SSE’s Feb. 4 trading statement and the BoE’s decision later this week

SSE shares edged up 0.04% to 2,422.93 pence by mid-morning Monday, fluctuating between 2,417 and 2,439 pence earlier in the session. National Grid gained 0.82% during the same period.

Big UK utilities have been jittery around rate moves, with investors eyeing them as dividend plays that rival bonds. The Bank of England is widely predicted to hold its benchmark rate at 3.75% this week. Traders are keenly watching for hints on whether policymakers might signal rate cuts soon. “We expect Bank Rate to be cut twice this year. The timing of the next cut is coming increasingly into question,” said Sanjay Raja at Deutsche Bank. Reuters

European shares dipped, dragged down by commodity-related stocks following a slide in energy and metals prices. Investors shifted cautiously into defensive sectors amid the unsettled mood.

SSE is gearing up for a key update soon. Their calendar marks a third-quarter trading statement on Feb. 4, followed by preliminary results set for May 28.

Investors often look to the Q3 update for clues on renewable output, the pace of network investments, and changes in financing—key for capital-intensive firms. With shares hovering near recent highs, even minor guidance adjustments can make a difference.

On Monday, SSE released its regular “total voting rights” update, detailing the current number of shares outstanding and the associated voting rights. TradingView

The filing showed the company has 1,215,471,728 ordinary shares issued, with 3,327,300 held in treasury and carrying no voting rights. This means total voting rights stand at 1,212,144,428, the number investors rely on as the denominator for shareholding disclosure thresholds under Financial Conduct Authority transparency rules.

Still, rates remain the main driver for the stock. Any change in the BoE’s stance can rapidly shift gilt yields, which in turn often drags utilities along, given their long-term cashflows and dividends tied to “risk-free” returns.

But sentiment can shift quickly. If inflation figures or central-bank signals lead markets to dial back expectations for rate cuts—or simply push yields upward—defensive sectors sensitive to rates, like utilities, may lose appeal despite consistent operational performance.

Stock Market Today

  • Semtech Investment Growth: $1000 in 2015 Now Worth $3,821
    May 19, 2026, 9:55 AM EDT. If you had invested $1,000 in Semtech (SMTC) a decade ago, your stake would now be worth $3,821.31, representing a 282.13% gain. Semtech, based in Camarillo, California, designs and markets analog and mixed-signal semiconductors for commercial uses across infrastructure, high-end consumer, and industrial sectors. In fiscal 2025, it reported $909.3 million in revenue, up 4.7% year-over-year. Semtech's products serve data centers, consumer electronics, and industrial applications such as IoT and automotive systems. This growth highlights the rewards of long-term investment in semiconductor companies amid evolving technology demands.

Latest articles

Bakkt Up Early After Director Buys $4.85M in Shares

Bakkt Up Early After Director Buys $4.85M in Shares

19 May 2026
Bakkt shares jumped 14.2% to $9.96 in pre-market trading Tuesday after a filing showed director Michael Alfred’s vehicle bought $4.85 million in stock. SEC documents said Alfred acquired 585,000 shares last week via Alpine Fox LP. CEO Akshay Naheta exercised options for 33,557 shares at $10 each. Bakkt recently reported Q1 revenue of $243.6 million, down sharply from a year earlier.
Relay Therapeutics Shares Rise In Pre-Market Ahead Of Key Drug Update

Relay Therapeutics Shares Rise In Pre-Market Ahead Of Key Drug Update

19 May 2026
Relay Therapeutics shares jumped 11.3% to $13.47 in premarket trading Tuesday after reporting a 60% volumetric response rate in 20 evaluable patients from its Phase 2 trial of zovegalisib for vascular anomalies. The company said 95% of patients saw some lesion reduction at 12 weeks. No patients discontinued due to adverse events. The regular Nasdaq session was set to open at 9:30 a.m. ET.

Popular

Intel Shares Edge Up as AI Chip Trade Runs Into Hurdles

Intel Shares Edge Up as AI Chip Trade Runs Into Hurdles

18 May 2026
Intel shares rose 0.3% to $109.10 in early New York trading Monday after last week’s selloff, as analysts raised price targets and President Trump commented on the U.S. government’s 10% stake, now valued above $50 billion. First-quarter revenue climbed 7% to $13.6 billion, with Data Center and AI sales up 22%. The iShares Semiconductor ETF fell 0.9%. Intel’s server CPU market share dropped to 54.9% in Q1, according to UBS.
ST Engineering share price slips after NeuSAR-2 satellite plan and Singapore’s new space agency
Previous Story

ST Engineering share price slips after NeuSAR-2 satellite plan and Singapore’s new space agency

Samsung Electronics stock price dives 6% in Seoul selloff — what to watch before Tuesday’s open
Next Story

Samsung Electronics stock price dives 6% in Seoul selloff — what to watch before Tuesday’s open

Go toTop